MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)

|||
Financial Ratios
2026-03-31
2025-12-31
2025-09-30
2025-06-30
P/E Ratio
-15.201 10.367 112.963
Return on Equity
3.392 -28 64.375 10.197
Net Profit Margin
9.651 -112 241.727 19.97
Debt to Asset Ratio
61.858 39.053 40.761 60.657
Cash Ratio
236.339 51.475 47.243 75.122
Quick Ratio
511.972 328.55 288.765 295.982
Current Ratio
580.931 410.226 382.479 386.274

Time Plot

Show the time plot by selecting a row from the table.